Existing glaucoma implants often cause discomfort and scarring that limit their long-term success
R&D Focus
Nanotechnology-enabled ocular implant
Innovative Solution
Avisi Technologies nanotechnology-enabled ocular implant is a multichannel, ultrathin, and nonfibrotic drainage implant that creates a new outflow pathway for the aqueous humor in the eye
Solution Effectiveness
Avisi Technologies approach helps remove excess fluid inside the eye, relieving high pressures that damage the optic nerve and cause open-angle glaucoma
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
$7.5M
Last Funding Amount
$4.06M
Last Funding Date
October 1, 2023
Startup Stage
Early Stage
Lead Investors
Gaingels, America's Seed Fund, Accanto Partners
People
Founders
Rui Jing Jiang
Brandon Kao
CEO
Rui Jing Jiang
Products
Product
VisiPlate
Demo Product or Complete Product?
Complete Product
Awards and Recognitions
Media Apperance
Mystrategist, Technical.ly
Something missing or incorrect on this page? Help us enrich this information
